MedTrace Logo

Intranasal Dexmedetomidine Sedation for Ophthalmic Examinations in Children

NCT02077712 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-05-03

No results posted yet for this study

Summary

2 ug/kg of intranasal dexmedetomidine could produce satisfactory sedation in more children for ophthalmic examinations than the sedative effect of 1ug/kg.

Conditions

  • Sniffs Drugs

Interventions

DRUG

intranasal dexmedetomidine

1 or 2 ug/kg of intranasal dexmedetomidine

Sponsors & Collaborators

  • Ministry of Health, China

    collaborator OTHER_GOV

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Haotian Lin, Ph.D. · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Xiaoliang Gan, Ph.D. · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Weirong Chen · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Yizhi Liu, Ph.D. · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02077712 on ClinicalTrials.gov